In a clinical trial, an experimental heart drug from AstraZeneca significantly reduced patients’ rate of death from heart attacks, strokes and other cardiovascular problems when compared to the blockbuster drug Plavix.
Read more here:
AstraZeneca Drug Beats Plavix






